Congratulations to Dr. Yuzhuo Wang on receiving $1.26M+ in CIHR funding to study aggressive neuroendocrine prostate cancer (NEPC), focusing on key regulators PROX1 and CHD7.Congrats Read more on VPC News! 🔗: prostatecentre.com/news/dr-y… #ProstateCancer #vancouverprostatecentre